Hospice News January 7, 2025
Amedisys’ (Nasdaq: AMED) has halted the divestiture of some of its home health and hospice locations to Texas-based VitalCaring.
Amedisys in June announced an agreement to sell some of its locations to the private equity-backed home health and hospice provider VitalCaring. The agreement included potentially more than 100 locations.
The VitalCaring transaction was contingent on approval of Amedisys’ $3.3 billion acquisition by the UnitedHealth Group (NYSE: UNH) subsidiary Optum. Amedisys planned to move forward with the VitalCaring divestiture in order to mitigate federal antitrust concerns surrounding its sale.
The news to cancel the divestiture comes after a recent court order issued by a federal judge in Delaware requiring that VitalCaring allocate 43% of future profits to Encompass Health (NYSE: EHC)...